A federal district judge today upheld the Department of Health and Human Services’ (HHS) authority to preapprove 340B rebate models, [...] …
Category: Regulatory
The Health Resources and Services Administration (HRSA) on Tuesday rolled out new grant terms that require federally qualified health centers [...] …
Three drugmakers and a drug industry tech firm are urging a federal appeals court to overturn a ruling that blocked [...] …
President Donald Trump’s recent executive order directing federal agencies to pursue “most favored nation” (MFN) pricing for prescription drugs could [...] …
A national 340B community health center organization, which has faced criticism for its partnership with a powerful drug industry trade [...] …
A major North Carolina health system has sued insurers Aetna Health and Humana for allegedly underpaying for 340B drugs purchased [...] …
A federal appellate court in Washington, D.C. is fast-tracking Novartis and Bristol Myers Squibb’s (BMS) appeal of a lower court [...] …
The Centers for Medicare and Medicaid Services (CMS) released new details this week to help stakeholders navigate the Inflation Reduction [...] …
For the third straight time in 2025, a federal audit has found a drug manufacturer overcharged covered entities for 340B [...] …
A major group purchasing organization (GPO) recently urged a Washington D.C. federal court to reject the federal government’s defense of [...] …